← Back to Search

Cardiac Resynchronization Therapy

CRT for Heart Failure

N/A

Waitlist Available

Research Sponsored by Anthony Tang

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial is comparing two different treatments for heart failure patients who have a particular kind of heart blockage. One group will receive standard treatment plus a new device, while the other group will receive standard treatment plus a different device.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

6-minute walk distance

NTproBNP measurement

Quality of Life (QoL) score

Secondary outcome measures

A composite of all-cause mortality and HF events

LV reverse remodeling (LVESVi on echocardiography)

LVEF

+2 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: CS-CRTExperimental Treatment1 Intervention

The experimental group will be treated with CRT in addition to optimal medical therapy for HF. In addition, the trial will further compare two methods of delivering CRT. One experimental group will receive BiV-CRT, while the second experimental group will receive Conduction System(CS)-CRT.

Group II: BiV-CRTExperimental Treatment1 Intervention

Group III: Control GroupActive Control1 Intervention

The control group will be treated with practice guideline optimal medical therapy for HF.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CRT

2008

Completed Phase 4

~860

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Anthony TangLead Sponsor

2 Previous Clinical Trials

2,811 Total Patients Enrolled

1 Trials studying Heart Failure

311 Patients Enrolled for Heart Failure

Media Library

CRT (Cardiac Resynchronization Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04582578 — N/A

Heart Failure Research Study Groups: BiV-CRT, CS-CRT, Control Group

Heart Failure Clinical Trial 2023: CRT Highlights & Side Effects. Trial Name: NCT04582578 — N/A

CRT (Cardiac Resynchronization Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04582578 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What potential outcome is this research project intending to demonstrate?

"The 12-month primary outcome of this research is the Quality of Life score, while further secondary objectives involve measuring Heart failure morbidity, Ventricular arrhythmia burden using device capture and adjudication by a blinded committee, and Left Ventricular Ejection Fraction (LVEF) via echocardiography."

Answered by AI

How many participants are involved in this research endeavor?

"Affirmative. Evidenced on clinicaltrials.gov, this medical experiment is actively enrolling participants and was first posted on the 3rd of November 2021. The most recent changes to its description were made on 19th November 2021, with a total of 370 individuals needed from one single site."

Answered by AI

Is this experiment actively seeking participants?

"Affirmative, the information found on clinicaltrials.gov suggests that this medical research is actively seeking participants. This trial was initially published on November 3rd 2021 and last updated a few weeks later, with 370 patients needing to be recruited at one site in particular."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Resynchronization for Ambulatory Heart Failure Trial in Patients With Preserved LV Function

Anthony Tang 2021. "Resynchronization for Ambulatory Heart Failure Trial in Patients With Preserved LV Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04582578.